Send to a Friend Share

Endo Pharma (ENDP) Completes Tender Offer for Remaining Shares of Penwest (PPCO)

September 20, 2010 4:18 PM EDT
ENDP Hot Sheet
Overall Analyst Rating:
    BUY (= Flat)

Revenue Growth %: +23.4%
Endo Pharma (Nasdaq: ENDP) today announced that it has successfully completed its tender offer by an indirect subsidiary, West Acquisition, for all the outstanding shares of Penwest Pharma (Nasdaq: PPCO).


Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!

You May Also Be Interested In


Related Categories

Corporate News, Mergers and Acquisitions

Add Your Comment





Follow StreetInsider.com On Twitter